跳至主要内容
临床试验/NCT02557230
NCT02557230招募中不适用

Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience

Assiut University1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
250
试验地点
1
主要终点
Event Free Survival (EFS)

研究概览

简要总结

The aim of this study is to identify demographic & disease characteristics in pediatric oncology patients diagnosed with one of genitourinary tumors & treatment outcomes in these patients.

详细描述

Background:

Tumors of the kidney, bladder, prostate, testis, and adrenal represent a large part of the adult urologic practice, but are relatively infrequent in children.

Genitourinary tumors contribute to pediatric solid tumors. Wilms tumor, rhabdomyosarcoma, and germ cell tumors are the most common malignant genitourinary tumors in children.

The natural history and management of these tumors in the pediatric age is different from that of the adults. As result of the successful work of several clinical trial groups in recent decades, there has been a significant improvement in their cure rates.

Patients & Methods:

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients whose age less than or equal to 18 years.
  • Patients diagnosed with any of neoplasms affecting the genitourinary system.

排除标准

  • Patients whose age more than 18 years.

结局指标

主要结局

Event Free Survival (EFS)

时间窗: Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years

Time from the date of initiation of treatment until disease progression, or death for any reason.

Overall survival (OS)

时间窗: Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years

Time from the date of initiation of treatment until death from any cause

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohammed Morsy, MD

Lecturer, Pediatric Oncology Department

Assiut University

研究点 (1)

Loading locations...

相似试验